Original news and analysis on international IP policy
A United States publisher of open source college textbooks – licensed under Creative Commons and fully remixable – has seen interest in its service increase more than 30-fold in the past several months, according to a press release [pdf] by…
Ongoing concerns in India that their legitimate generic drug shipments are being delayed as potential counterfeits while in transit through Europe may reach the dispute settlement body at the World Trade Organization, according to sources.
Authorities in the European Union and the United States have recently taken a tougher stance against reverse payments - patent settlements whereby, according to many competition experts, dominant drug companies buy off potential rivals.
Indian generics manufacturer Cipla can get marketing approval for its generic cancer treatment Soranib, the Delhi High Court ruled Tuesday, and the Indian drug regulatory authority does not have to check its patent status first. The court this week rejected a complaint by drug multinational Bayer against the Union of India, the Drug Controller General of India and generic drug producer Cipla.
Bayer sought a court order requiring DCGI to consider the patent status of kidney cancer drug, sorafenib tosylate (sold under the brand name Nexavar), before granting marketing approval for a generic version of the drug.
At issue was whether it is legitimate to link a potential violation of IP rights to processes regulating a drug’s entry onto the market that are generally based on drug quality, efficacy and safety.
A potentially paradigm-shifting legal case that could restrict the granting of business method patents in the United States, Bilski v. Doll has attracted the attention of policy makers world-wide, who expect its outcome to influence the international patent system (IPW,…
The Intellectual Property Watch Monthly Edition features top news on international IP policymaking, the latest on who is coming and going in the international IP community, news briefs and more. The August/September edition is now available for subscribers.
A group of experts working as a think-tank for the United Nations Human Rights Council raised the issue of patents and food at a meeting this week. Meanwhile, a new report by the UN Special Rapporteur on the Right to Food expected to be available at the end of August will focus on the intersection between intellectual property and the human right to food.
A group of US congressional members have sent a letter to US Commerce Secretary Gary Locke calling for a temporary arrangement between the Department of Commerce (DOC) and the Internet Corporation for Assigned Names and Numbers (which manages technical aspects…
The influential United Nations Economic and Social Council (ECOSOC) ended its 2009 substantive session on 31 July, after a month-long coordinating body meeting in Geneva which yielded resolutions on several topics such as public health, science and technology, human rights, environment and sustainable development issues.
Online auction site eBay, the owner of popular, proprietary voice-over-internet protocol software Skype, has warned that the service might not continue if it loses an intellectual property dispute with Joltid, the company from which it licences Skype’s core technology. “If…
NEW YORK - Patent lawyers from financial services companies and other firms this week said they are hopeful that change at the US Patent and Trademark Office will bring solutions to their concerns with the business method patents, application backlogs, patent quality problems, transparency and other issues.
Last October, a United States appellate court shifted the country’s patent law dramatically, moving the nation closer to other countries’ standards on what inventions can be patented. The Federal Circuit Court of Appeals (often called America’s “patent court”) overruled its own seminal precedent and sharply cut back on the types of methods and processes that are eligible for patent protection. The ruling put thousands of patents under a cloud, including many business method patents and financial method patents.
This controversial ruling will soon be reviewed by the US Supreme Court. The resulting decision in Bilski v. Doll could become a milestone in US patent law, with repercussions around the world.